Clinical Trials in Austin

Showing 3981-4000 of 10,906 trials

Safety and Effectiveness Study of the Zenflow Spring System

NCT04987138

Evaluate the safety and effectiveness of the Zenflow Spring System in relieving LUTS associated with BPH.

BPH (Benign Prostatic Hyperplasia)Lower Urinary Tract Symptoms (LUTS)

Zenflow, Inc.279 participantsStarted Sep 2021

Los Angeles, California, United States • Glenview, Illinois, United States • Las Vegas, Nevada, United States +4 more locations

COMPLETEDPhase 3< 1 mile

A Long-term Treatment With B-VEC for Dystrophic Epidermolysis Bullosa

NCT04917874

This is a 112-week (approximately two-year) open-label extension study of Beremagene Geperpavec (B-VEC), for participants aged 2 months and older, who have been diagnosed with Dystrophic Epidermolysis Bullosa (DEB). Participants will be dosed weekly with the topical B-VEC therapy. The primary endpoint will be to assess long term safety and tolerability of the topical gene therapy. The study is for those who participated in Phase 3 study, as well as, new participants who were unable to participate in the Phase 3 study, who meet all enrollment criteria.

Dystrophic Epidermolysis BullosaDEB - Dystrophic Epidermolysis BullosaRecessive Dystrophic Epidermolysis Bullosa+1 more

Krystal Biotech, Inc.47 participantsStarted May 2021

Rancho Santa Margarita, California, United States • Redwood City, California, United States • Coral Gables, Florida, United States +3 more locations

Safety and Effectiveness Study of the Zenflow Spring System

A Long-term Treatment With B-VEC for Dystrophic Epidermolysis Bullosa

Find Trials by Condition in Austin

Treatment Effects of Subcutaneous Injections of Pentosan Polysulfate Sodium vs Placebo in Participants With Knee OA Pain

An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-2)

Effects of Yoga on Sodium-induced Pressor Responses in African American Adults

Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)

Financial Incentives, Randomization With Stepped Treatment Trial

DWI in Assessing Treatment Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy

Open-Label Extension Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome

A SAD/MAD to Assess the Safety, PK/PD of FT-4202 in Healthy Volunteers and Sickle Cell Disease Patients

A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts

TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801)

Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Lumbar Pain

Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE)

Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer

Evaluation of Product Performance of a New Silicone Hydrogel Multifocal Contact Lens

Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies Avalglucosidase Alfa and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BIIB107 in Healthy Adult Participants

Study to Evaluate the Safety and Pharmacokinetics of Efmarodocokin Alfa in Combination With Standard of Care in Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

A Study of Atezolizumab in Locally Advanced or Metastatic Urothelial or Non-Urothelial Carcinoma of the Urinary Tract